President-Elect Description

April 25, 2023

Position: President-Elect

Term: Three Years (including President and Immediate Past President positions)

Eligibility Criteria for President-Elect:

  • Active member in good standing consecutively for the past five years and recognized as a leader in the field of endocrinology.
  • Candidates should have demonstrated leadership skills and familiarity with Society priorities.
  • Candidates must possess the following board-approved competencies that will support their responsibilities: organizational knowledge and stewardship; strategic thinking and leadership; communication; and collaboration.

Major Responsibilities of the President-Elect: To embrace the Society’s mission, vision, and Strategic Plan and provide leadership in their effective implementation and ongoing assessment; to serve as spokesperson, ambassador, and representative of the Endocrine Society as follows:

  • Serve as a member on the following committees: Board of Directors, Executive Committee, Performance and Compensation Steering Committee, and ex-officio (non-voting) member of the Finance & Audit and Publications Committees.
  • Appoint committee members for vacancies occurring in his/her year as President-Elect.
  • Contribute to the Society’s achievement of its Strategic Plan (SP) by participating in an annual discussion on SP priorities, ensuring the Board consistently conducts environmental scanning and looks for trends and potential opportunities.
  • Play a role as consensus builder on internal and external issues facing members and the Society.
  • Work closely with the Chief Executive Officer and the Executive Committee to ensure the effective operation of the governance-staff partnership.

Expected Time Commitment: The President-Elect position will require approximately 27-28 days of physical presence at meetings. 

The President-Elect is expected to participate in the following meetings/conference calls during his/her term as follows:

  • All in-person meetings of the Board of Directors (3), as well as any specially called meetings or conference calls as appropriate.
  • Conference calls with staff, bi-weekly or as frequent as needed.
  • Committee appointments conference calls, totaling approximately one day. 
  • Executive Committee meetings (as needed), conference calls, and one in-person Performance and Compensation Committee meeting.
  • Endocrine Society Annual Meeting, ENDO.
  • Finance & Audit Committee meetings (3 per year) and quarterly conference calls. 
  • Publications Committee meetings and conference calls as appropriate.
  • Capitol Hill visits (approximately 2 per year) and other meetings with key policy makers as needed (if possible, not mandatory). 

Additional requirements for Presidential Officers:

Additional restrictions apply to Presidential Officers to ensure a clear separation between their roles as Society officers and their scientific/medical expertise, as follows:

  • Invited medical/scientific presentations, public speaking engagements, and press interviews:

During the three years as a Presidential Officer, he/she should provide complete disclosure at the beginning of each presentation to separate his/her role as Society officer from his/her scientific/medical expertise. For example, the disclosure could include a statement as follows: The following presentation represents my research/medical opinion and does not represent the views of the Endocrine Society in my role as President (or President-Elect or Immediate Past President as appropriate). If applicable the disclosure statement should include his/her current grant funding, membership on Advisory Boards, and relationships with Pharma. The content of the Presidential Officer’s talk also should reflect the Officer’s own work and expertise; however, presentations made in both US and international venues should abide by ACCME rules, and industry prepared slides (with or without a Pharma identification logo) should not be included in the presentations. Finally, in response to questions from the audience he/she also should clearly separate their role as Society Officer from their scientific/medical expertise.

  • Honoraria from commercial organizations including biomedical companies including Pharma: 

During the three years corresponding to their position as a Society presidential officer, honoraria should not be accepted from commercial organizations. 

  • Presidential Officers who have relevant financial relationships with biomedical companies including Pharma (as described in ES disclosures statements) should anticipate that the ES leadership will work with the officer to develop a formal plan to address any apparent conflict of interest. For this reason, all nominees interested in being considered for the President-Elect position will be asked to submit their updated conflict of interest statement at the time they submit their nomination packet.
Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.